Dr oec. troph. Johanna Breilmann

M. Sc. nutritionist
Research assistant

Phone: 08221 96-29209
Fax: 08221 96-28172

E-mail: johanna.breilmann@uni-ulm.de

Johanna Breilmann is a nutritionist and has been a research assistant at the Department of Psychiatry and Psychotherapy II at the University of Ulm since 2016. She is project coordinator of the "IMPPETUS" and "EPPIK" projects funded by the Innovation Committee of the Federal Joint Committee (G-BA). She also works on systematic reviews and meta-analyses on psychiatric and nutritional psychiatric topics, including international Cochrane Reviews.
Previously, Johanna Breilmann worked and completed her doctorate at the Institute of Nutritional Science at the University of Giessen, where she was involved in the organisation, implementation and data analysis of the Giessen Senior Citizens Long-Term Study (GISELA study).

Projects

EPPIK - Examination of the suitability of the "platform model" as an instrument for staff assessment in psychiatric and psychosomatic clinics

IMPPETUS - Implementation of the patient guideline on psychosocial therapies for patients with severe mental illnesses

Systematic reviews / meta-analyses on:

  1. Efficacy of vortioxetine and benzodiazepines
  2. Dose-response relationship in cognitive behavioural therapies
  3. Nutritional interventions for people with severe mental illness in Germany

Nutrition for people with mental illness

Block course: "Medical psychology and medical sociology"

since 2016Research assistant at the Department of Psychiatry and Psychotherapy II, University of Ulm
2008 - 2016Research assistant, Justus Liebig University Giessen, Institute for Nutritional Science
2014Dr oec. troph., Justus Liebig University Giessen
2007M. Sc. Nutritional Sciences, Justus Liebig University Giessen
2005B. Sc. Ecotrophology, Justus Liebig University Giessen

 

Scientific articles
  1. Schneider C, Breilmann J, Reuter B, Becker T, Kösters M: Systematic evaluation of the 'efficacy-effectiveness gap' in the treatment of depression with venlafaxine and duloxetine. Acta Psychiatr Scand 2021; Mar 4. doi: 10.1111/acps.13293.
  2. Breilmann J, Kilian R, Riedel-Heller SG, Gühne U, Hasan A, Falkai P, Allgöwer A, Muche R, Becker T, Ajayi K, Brieger P, Frasch K, Heres S, Jäger M, Küthmann A, Putzhammer A, Schmauß M, Schneeweiß B, Schwarz M, Kösters M. Implementation of the patient version of the evidence-based (S3) guideline for psychosocial interventions for patients with severe mental illness (IMPPETUS): study protocol for a cluster randomised controlled trial. Trials 2020; 21(1):275.
  3. Breilmann J, Müller-Stierlin A, Gühne U, Kilian R, Becker T, Kösters M: Weight management in people with severe mental illness. Nutrition Review 2020; 67(2):M100-M107.
  4. Breilmann J, Garlanda F, Guaiana G, Barbui C, Cipriani A, Castellazzi M, Bighelli I, Davies SJC, Furukawa TA, Koesters M: Benzodiazepines versus placebo for panic disorder in adults (Review). Cochrane Database Syst Rev 2019; 3:CD010677.
  5. Breilmann J, Furukawa TA, Becker T, Koesters M. Differences in the placebo response in duloxetine and venlafaxine trials. Acta Psychiatr Scand 2018; 137(6):472-480.
  6. Koesters M, Ostuzzi G, Guaiana G, Breilmann J, Barbui C: Vortioxetine for depression in adults. Cochrane Database Syst Rev 2017; 7:CD011520.
  7. Breilmann J, Pons-Kühnemann J, Brunner C, Richter M, Neuhäuser-Berthold M: Effect of antioxidant vitamins on the plasma homocysteine level in a free-living elderly population. Ann Nutr Metab 2010; 57:177-182.
  • Acta Psychiatrica Scandinavica
  • Epidemiology and Psychiatric Sciences
  • Social Psychiatry and Psychiatric Epidemiology (SPPE)